NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

STROKE is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of neurology, cardiology, and specialized nursing. With an impressive impact factor and consistently ranked in the Q1 category across multiple disciplines—such as Advanced and Specialized Nursing, Cardiology, and Neurology—this journal serves as a crucial platform for researchers and healthcare professionals. It spans a rich historical context from 1970 to 2024, offering invaluable insights into stroke research and related cerebral vascular issues. The journal is committed to disseminating high-quality research that informs clinical practices and guides policy-making in public health. With a focus on empirical studies and clinical trials, STROKE stands as an essential resource for those invested in the complexities of neurological interventions and cardiovascular health. Ensure your access to this influential publication as it shapes the future of medical science and patient care.

The European Stroke Journal, published by SAGE Publications Ltd, is a pivotal resource in the domains of Cardiology and Neurology, reflecting its commitment to advancing knowledge and research in these critical areas of medicine. Since its inception in 2016, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in both Cardiology and Neurology (clinical) as of 2023, placing it among the top quartile publications in these fields. With a prominent position, ranked 65th and 72nd respectively in Scopus for Cardiology and Neurology, the journal caters to a diverse audience of researchers, clinicians, and students dedicated to improving stroke treatment and prevention strategies. Although it operates under a traditional access model, its impactful publications are essential for anyone involved in stroke research, ensuring they remain at the forefront of scientific developments and clinical practices.

NEUROIMAGING CLINICS OF NORTH AMERICA is a premier peer-reviewed journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the evolving field of neuroimaging and its applications in clinical practice. Established in 1993, this journal has become a pivotal resource for researchers, professionals, and students alike, providing in-depth articles, reviews, and case studies that address both cutting-edge advancements and standard practices in neuroimaging. With its impressive credentials, ranking in the top quartiles of various medical categories—including Q2 in Medicine (Miscellaneous) and Q2 in Radiology, Nuclear Medicine, and Imaging—the journal is vital for advancing knowledge and clinical applications in the disciplines of neurology and radiology. Although it does not offer open access, the journal maintains a robust reputation with a broad readership, embodying a commitment to excellence in medical literature. The ISSN number is 1052-5149 and the E-ISSN number is 1557-9867, ensuring the accessibility and dissemination of high-quality neuroimaging research.

CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

Annals of Neurosciences, published by SAGE Publications Ltd, is a distinguished journal that serves the vibrant field of neuroscience. With an ISSN of 0972-7531 and E-ISSN 0976-3260, it has been a significant platform for advancing knowledge in various aspects of neuroscience since its inception. The journal, positioned in the Q3 category in the realm of neurosciences (miscellaneous) as of 2023, aims to bridge the gap between basic research and clinical practices, providing a comprehensive forum for the dissemination of innovative research, reviews, and insights within the field. With a convergence period from 2011 to 2024, it continually emphasizes the importance of interdisciplinary approaches in understanding neural mechanisms and their implications for mental health and neurological disorders. The journal's open access options ensure that research findings are widely available, fostering collaboration and dialogue among researchers, professionals, and students globally. Located in London, England, the Annals of Neurosciences stands out as an essential publication for those aiming to stay at the forefront of neuroscience research and application.